错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Genetic (co)variation for resistance to white spot syndrome virus, acute hepatopancreatic necrosis, and overall pond survival in Litopenaeus vannamei

  • Reyes López-Ordaz,
  • Alejandra Caballero-Zamora,
  • José M. Yáñez,
  • Leobardo Montoya-Rodríguez,
  • Bruno Gómez-Gil,
  • Sonia A. Soto Rodríguez,
  • Alfonso Martínez Ortega,
  • Juan C. Quintana-Casares,
  • Héctor Castillo-Juárez,
  • Gabriel R. Campos-Montes

摘要

This study aimed to assess the genetic parameters associated with survival against acute hepatopancreatic necrosis (S_AHPND) and white spot syndrome virus (S_WSSV) in controlled challenge settings, as well as survival in commercial ponds (S_COMERCIAL) and within a high biosecurity genetic nucleus (S_NUCLEUS). Two lines were studied: one with a history of resistance to WSSV (RES) and another focused on rapid growth but susceptible to WSSV (GRO). All traits were analyzed as binary (alive or dead), and (co)variance components were estimated using a within-line multivariate linear animal model. Heritabilities for S_AHPND and S_WSSV ranged from 0.09 to 0.15 and from 0.01 to 0.14, respectively. In the case of S_COMMERCIAL, heritabilities spanned from 0.01 to 0.23, and for S_NUCLEUS, they were between 0.02 and 0.08. Notably, genetic correlations (rg) between S_WSSV and S_AHPND exceeded 0.50 in both lines. When examining S_COMMERCIAL, rg with S_AHPND in GRO were estimated at values between 0.25 and 0.51, while in RES, they ranged from 0.23 to 0.62. Regarding S_WSSV, rg ranged from − 0.04 to 0.60 in GRO and from 0.22 to 0.76 in RES. The rg between S_NUCLEUS and the other traits fell within the range of − 0.15 to 0.74. Spearman correlations between the family breeding values for all four traits were estimated to be between 0.31 and 0.66. In summary, this study found that additive genetic variation for these traits ranged from low to moderate. The results suggest the potential for a correlated response in overall commercial survival (S_COMERCIAL) when selecting for improved specific-pathogen resistance against both S_AHPND and S_WSSV.